HK1125376A1 - Salt of cd 80 antagonist cd80 - Google Patents

Salt of cd 80 antagonist cd80

Info

Publication number
HK1125376A1
HK1125376A1 HK09104229.6A HK09104229A HK1125376A1 HK 1125376 A1 HK1125376 A1 HK 1125376A1 HK 09104229 A HK09104229 A HK 09104229A HK 1125376 A1 HK1125376 A1 HK 1125376A1
Authority
HK
Hong Kong
Prior art keywords
antagonist
salt
Prior art date
Application number
HK09104229.6A
Other languages
English (en)
Inventor
Ian Richard Matthews
Original Assignee
Medigene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene Ag filed Critical Medigene Ag
Publication of HK1125376A1 publication Critical patent/HK1125376A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
HK09104229.6A 2006-02-22 2009-05-07 Salt of cd 80 antagonist cd80 HK1125376A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0603522.4A GB0603522D0 (en) 2006-02-22 2006-02-22 Kinase inhibition
PCT/GB2007/000550 WO2007096588A1 (en) 2006-02-22 2007-02-19 Salt of cd 80 antagonist

Publications (1)

Publication Number Publication Date
HK1125376A1 true HK1125376A1 (en) 2009-08-07

Family

ID=36178528

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104229.6A HK1125376A1 (en) 2006-02-22 2009-05-07 Salt of cd 80 antagonist cd80

Country Status (20)

Country Link
US (3) US20090221590A1 (xx)
EP (1) EP1991548B1 (xx)
JP (1) JP5102785B2 (xx)
KR (1) KR101433738B1 (xx)
CN (1) CN101384595B (xx)
AU (1) AU2007217170B2 (xx)
BR (1) BRPI0708114B8 (xx)
CA (1) CA2643668C (xx)
DK (1) DK1991548T3 (xx)
EA (1) EA014101B1 (xx)
ES (1) ES2449569T3 (xx)
GB (1) GB0603522D0 (xx)
HK (1) HK1125376A1 (xx)
IL (1) IL192954A (xx)
NZ (1) NZ570055A (xx)
PL (1) PL1991548T3 (xx)
PT (1) PT1991548E (xx)
UA (1) UA91904C2 (xx)
WO (1) WO2007096588A1 (xx)
ZA (1) ZA200806508B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489388T1 (de) * 2003-03-14 2010-12-15 Medigene Ltd Immunmodulierende heterocyclische verbindungen
US7932253B2 (en) 2004-08-09 2011-04-26 Medigene Ag Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
JP5628816B2 (ja) * 2008-10-31 2014-11-19 ツェー・アー・イー・エルバイオサイエンスシーズ、ゲーエムベーハー リコフェロンのコリンおよびトロメタミン塩
US9169266B2 (en) * 2010-02-10 2015-10-27 Kissei Pharmaceutical Co., Ltd. Salt of fused heterocyclic derivative and crystal thereof
UA109287C2 (uk) * 2010-11-02 2015-08-10 Солі органічного аміну похідних амінобензойної кислоти і спосіб їх одержання
EP4119128A1 (en) * 2021-07-13 2023-01-18 Dr. Falk Pharma Gmbh Pharmaceutical composition for the oral administration of poorly soluble drugs comprising an amorphous solid dispersion

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670350A (en) * 1952-08-08 1954-02-23 Nepera Chemical Co Inc Method of preparing choline salt of theophylline
US3576637A (en) * 1967-04-20 1971-04-27 Konishiroku Photo Ind Lith-type of emulsion containing pyrozolone
US3778150A (en) * 1971-10-27 1973-12-11 K Aston Printing of photographic colour negatives
JPS523818A (en) * 1975-06-26 1977-01-12 Hoffmann La Roche Salt of penicillanic acid
US4591589A (en) * 1985-01-16 1986-05-27 Roussel Uclaf 2-aryl pyrazolo[4,3-c]cinnolin-3-ones
DE3903993A1 (de) * 1989-02-10 1990-08-16 Basf Ag Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus
IT1290448B1 (it) * 1997-04-01 1998-12-03 Schiena Michele Giuseppe Di Nimesulide sale di colina,metodo di preparazione e composizioni farmaceutiche che lo contengono
ATE489388T1 (de) 2003-03-14 2010-12-15 Medigene Ltd Immunmodulierende heterocyclische verbindungen
TW200526638A (en) * 2003-10-22 2005-08-16 Smithkline Beecham Corp 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
GB0325644D0 (en) * 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
US7932253B2 (en) * 2004-08-09 2011-04-26 Medigene Ag Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
WO2006083687A1 (en) * 2005-01-28 2006-08-10 Cardiome Pharma Corp. Crystal salt of xanthine oxidase inhibitors

Also Published As

Publication number Publication date
UA91904C2 (xx) 2010-09-10
GB0603522D0 (en) 2006-04-05
ES2449569T3 (es) 2014-03-20
BRPI0708114B1 (pt) 2020-02-04
BRPI0708114B8 (pt) 2021-05-25
JP2009527538A (ja) 2009-07-30
PL1991548T3 (pl) 2014-05-30
EP1991548B1 (en) 2013-12-11
US20180265514A1 (en) 2018-09-20
JP5102785B2 (ja) 2012-12-19
EP1991548A1 (en) 2008-11-19
AU2007217170A1 (en) 2007-08-30
KR101433738B1 (ko) 2014-08-25
DK1991548T3 (en) 2014-03-10
IL192954A (en) 2015-01-29
EA200801875A1 (ru) 2008-12-30
CN101384595B (zh) 2011-02-09
KR20080103523A (ko) 2008-11-27
IL192954A0 (en) 2009-02-11
WO2007096588A1 (en) 2007-08-30
EA014101B1 (ru) 2010-08-30
CA2643668A1 (en) 2007-08-30
BRPI0708114A2 (pt) 2011-05-17
PT1991548E (pt) 2014-03-10
NZ570055A (en) 2011-08-26
US20090221590A1 (en) 2009-09-03
CA2643668C (en) 2014-05-13
CN101384595A (zh) 2009-03-11
AU2007217170B2 (en) 2012-02-02
US20120004237A1 (en) 2012-01-05
ZA200806508B (en) 2009-06-24

Similar Documents

Publication Publication Date Title
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
PL2094263T3 (pl) Pochodne 2-adamantylo-butyroamidowe jako selektywne inhibitory 11beta-HSD1
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
ZA200710951B (en) Piperidinyl-substituted isoquinolone derivatives as Rhokinase inhibitors
GB0722216D0 (en) Use of crth2 antagonist compounds
GB0722203D0 (en) Use of CRTH2 antagonist compounds
HK1200440A1 (zh) 種抑制劑的結晶形式
IL189933A0 (en) Rna antagonist compounds for the inhibition of apo-b100 expression
IL195010A0 (en) Bicyclic derivatives as cetp inhibitors
ZA200806983B (en) Amide derivative or salt thereof
GB0621607D0 (en) Inhibitors of c-Met
IL198462A0 (en) Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors
IL185757A0 (en) Methods of decreasing calcifcation
IL196136A0 (en) Aminoindane derivative or salt thereof
GB0622084D0 (en) Inhibitors of HSP90
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
HU0600293D0 (en) New rosuvastatine salt
IL185470A0 (en) Novel salt of quinuclidine derivative
GB0705854D0 (en) Methods of construction
HK1125376A1 (en) Salt of cd 80 antagonist cd80
EP2042499A4 (en) SALTS OF MORPHOLINE COMPOUND
ZA200706292B (en) Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
IL194873A0 (en) Methods for reducing 7/9-nitrotetracycline derivatives
PL381715A1 (pl) Nowe pochodne piperazynowe dialkilooksindoli

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240219